Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Ischemic Stroke From Large Vessel Occlusion: early-phase trial registry
2 of 2 indexed Acute Ischemic Stroke From Large Vessel Occlusion trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Acute Ischemic Stroke From Large Vessel Occlusion: 2 US clinical trials tracked, 2 recruiting.
Acute Ischemic Stroke From Large Vessel Occlusion is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Anaconda Biomed S.L., running 1 of these trials.
Enrollment posture brief
Registry condition acute-ischemic-stroke-from-large-vessel-occlusion
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Acute Ischemic Stroke From Large Vessel Occlusion lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acute Ischemic Stroke From Large Vessel Occlusion on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acute Ischemic Stroke From Large Vessel Occlusion is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
Anaconda Biomed S.L.
NCT06370182
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
University of Pennsylvania
NCT06904911
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Acute Ischemic Stroke From Large Vessel Occlusion records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acute Ischemic Stroke From Large Vessel Occlusion trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acute Ischemic Stroke From Large Vessel Occlusion page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Acute Ischemic Stroke From Large Vessel Occlusion trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Anaconda Biomed S.L. sponsors the most Acute Ischemic Stroke From Large Vessel Occlusion trials on record, review their full trial history before evaluating a specific study. See Anaconda Biomed S.L.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Ischemic Stroke From Large Vessel Occlusion condition card totals 2 registered trials; most-linked intervention intra-arterial tenecteplase administration; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.